Key Highlights: Implications:The acquisition gives ChrysCapital control of a long-established branded-generics platform with trusted brands such as Voveran, Calcium Sandoz and Tegrital, positioning th...
Key Highlights: Implication: This divestment signals multinational pharma firms accelerating exits from legacy India operations, potentially pressuring peers like Roche and Sanofi to restructure...
